CliffBio
small molecule

BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN

ASPIRIN

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameBAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
Active ingredientASPIRIN
Strength500MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2001
Marketing statusDISCN

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.